Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01259271 · ClinicalTrials.gov registry record · Early Phase 1
Selective Nerve Stimulation (SNS) Pilot Study
A Early Phase 1 study, sponsored by Codman & Shurtleff.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 60
- Enrollment target
NCT01259271 is a Early Phase 1 study that has completed, run by Codman & Shurtleff. The registered enrollment target is 60 participants.
The verdict
NCT01259271, a Early Phase 1 study, has completed, sponsored by Codman & Shurtleff.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to examine if a new device, the SNS (Selective Nerve Stimulator), is effective in changing the way nerves work as pain killing drugs sometimes do. During this study, the study team will place 2 adhesive patches on the inside of one of the wrists of the non-dominant hand (if the subject is right-handed the electrodes will be placed on the subject's left wrist) of the study subject. These patches will be connected by wires (leads) to a small box with a headphone jack. This is designed to provide gentle electrical stimulation through the skin. This study will look at the amount of change from normal nerve function, the sensory effects (feeling, sensations in the body), and any changes the subject has when performing the 2 hour tests. The safety of the study device will also be evaluated.
Interventions
- DEVICE Selective Nerve Stimulation (SNS) stimulator device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-11-01 |
| Est. Completion | 2011-02-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01259271
The ClinicalTrials.gov registry entry for NCT01259271 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Codman & Shurtleff, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Selective Nerve Stimulation (SNS) stimulator device is the first listed.
NCT01259271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01259271 about?
NCT01259271 is a clinical study titled "Selective Nerve Stimulation (SNS) Pilot Study". The purpose of this study is to examine if a new device, the SNS (Selective Nerve Stimulator), is effective in changing the way nerves work as pain killing drugs sometimes do. During this study, the study team will place 2 adhesive patches on the inside of one of the wrists of the non-dominant hand ...
What is the current status of trial NCT01259271?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 60 participants. The study started on 2010-11-01. Estimated completion is 2011-02-01.
What interventions are being tested in trial NCT01259271?
The interventions under investigation include: Selective Nerve Stimulation (SNS) stimulator device (DEVICE).
Who is sponsoring clinical trial NCT01259271?
This trial is sponsored by Codman & Shurtleff, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.